Arcturus Therapeutics Holdings Inc (ARCT)
27.93
+2.36
(+9.23%)
USD |
NASDAQ |
May 01, 16:00
27.93
0.00 (0.00%)
After-Hours: 17:59
Arcturus Therapeutics Holdings Profit Margin (Quarterly): -46.68% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -46.68% |
| September 30, 2023 | -37.40% |
| June 30, 2023 | -549.4% |
| March 31, 2023 | 63.66% |
| December 31, 2022 | 73.32% |
| September 30, 2022 | -263.8% |
| June 30, 2022 | -79.59% |
| March 31, 2022 | -975.8% |
| December 31, 2021 | -667.3% |
| September 30, 2021 | -2.22K% |
| June 30, 2021 | -2.73K% |
| March 31, 2021 | -2.65K% |
| December 31, 2020 | -1.39K% |
| September 30, 2020 | -900.3% |
| June 30, 2020 | -442.0% |
| Date | Value |
|---|---|
| March 31, 2020 | -369.5% |
| December 31, 2019 | -370.2% |
| September 30, 2019 | -224.0% |
| June 30, 2019 | -6.75% |
| March 31, 2019 | -158.3% |
| December 31, 2018 | -13.34% |
| September 30, 2018 | -124.2% |
| June 30, 2018 | -417.0% |
| March 31, 2018 | -277.6% |
| December 31, 2017 | -261.4% |
| September 30, 2017 | -96.39% |
| June 30, 2017 | -29.22% |
| March 31, 2017 | |
| December 31, 2016 | 83.92% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-2.73K%
Minimum
Jun 2021
73.32%
Maximum
Dec 2022
-725.3%
Average
-370.2%
Median
Dec 2019
Profit Margin (Quarterly) Benchmarks
| AIM ImmunoTech Inc | -19.35K% |
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | -57.64% |
| Electromed Inc | 12.23% |
| Armata Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -10.30% |
| Return on Assets | -6.64% |
| Return on Invested Capital | -9.75% |
| Operating Margin (Quarterly) | -72.86% |
| Return on Net Operating Assets | -38.71% |